ABSTRACT
About half of the US population is sensitized to one or more allergens, as found by a National Health and Nutrition Examination Survey (NHANES). The most common treatment for seasonal allergic responses is the daily use of oral antihistamines, which can control some of the symptoms, but are not effective for nasal congestion, and can be debilitating in many patients. Peptide immunotherapy is a promising new approach to treat allergic airway diseases. The small size of the immunogens cannot lead to an unwanted allergic reaction in sensitized patients, and the production of peptides with sufficient amounts for immunotherapy is time- and cost-effective. However, it is not known what peptides are the most effective for an immunotherapy of allergens. We previously produced a unique monoclonal antibody (mAb) E58, which can inhibit the binding of multiple groups of mAbs and human IgEs from patients affected by the major group 1 allergens of ragweed (Amb a 1) and conifer pollens (Jun a 1, Cup s 1, and Cry j 1). Here, we demonstrated that a combined approach, starting from two linear E58 epitopes of the tree pollen allergen Jun a 1 and the ragweed pollen allergen Amb a 1, and residue modifications suggested by molecular docking calculations and peptide design could identify a large number of high affinity binding peptides. We propose that this combined experimental and computational approach by structural analysis of linear IgE epitopes and peptide design, can lead to potential new candidates for peptide immunotherapy.
Subject(s)
Anti-Allergic Agents/pharmacology , Antibodies, Monoclonal/metabolism , Peptides/chemistry , Peptides/metabolism , Peptides/pharmacology , Animals , Anti-Allergic Agents/chemistry , Anti-Allergic Agents/immunology , Antigens, Plant/chemistry , Antigens, Plant/immunology , Epitopes/chemistry , Epitopes/immunology , Female , Humans , Immunoglobulin E/metabolism , Immunotherapy/methods , Mice, Inbred BALB C , Molecular Docking Simulation , Peptides/immunology , Plant Extracts/immunology , Plant Proteins/chemistry , Plant Proteins/immunology , Pollen/immunologyABSTRACT
BACKGROUND: Mountain cedar pollen is recognized as a major cause of seasonal hypersensitivity in the US. We describe here that a subgroup of these patients also suffer from pollen food allergy syndrome (PFAS). OBJECTIVE: We performed this study to determine the frequency of PFAS among patients with mountain cedar hypersensitivity. METHODS: We performed mail-out/telephone surveys of 800 mountain cedar-sensitive patients in Austin, TX. The subjects for this survey were selected by telephone screening, and skin and serologic testing. We performed immunoblot inhibition assay and mass spectrometry (MS) to identify the allergens that cause PFAS. RESULTS: Of the 28 patients with suspected food allergies, 15 had clinical manifestations of PFAS. Eleven of them had positive skin tests to tomato, six to banana, and one to apple. The subjects with PFAS have stronger cutaneous and in vitro reactivity to cedar pollen. The intensities of the tomato and banana reactivity were correlated with the cedar reactivity. The results of the ImmunoCAP inhibition experiments demonstrated a strong cross-reactivity between IgE antibodies to cedar pollen and fruits. This suggested that their primary sensitization was to cedar pollen, since absorption with cedar pollen extract strongly inhibited reactivity to each of the fruits, while the absorption with tomato extract did not significantly inhibit IgE binding to cedar extract. We determined that polygalacturonase 2 A (PG2 A) in tomato is the cause of PFAS. CONCLUSION: This is the first report of a PFAS in patients with mountain cedar pollinosis. Sensitivity to tomato, banana, and apple should be considered in cedar-sensitive patients.
Subject(s)
Allergens/immunology , Cedrus/immunology , Food Hypersensitivity/immunology , Pollen/immunology , Solanum lycopersicum/immunology , Cross Reactions/immunology , Fruit/immunology , Humans , Immunoglobulin E/immunology , Skin Tests/methodsABSTRACT
We recently described a dominant role for conformational epitopes on the group 1 allergen of the mountain cedar (Juniperus ashei, Cupressaceae), Jun a 1, in pollen hypersensitivity in South Central U.S.A. Since these epitopes are surface exposed and are likely to be flexible, they may be susceptible to molecular or physical perturbations. This may make Jun a 1 a potential target for new forms of therapy for cedar pollinosis. Here, we describe a mouse monoclonal antibody, termed E58, which binds to the group 1 allergens of the cedar pollens from three highly populated regions of the world (central U.S.A., France and Japan). Upon binding to these allergens, E58 strongly reduces the binding of patient's IgE antibodies to these dominant allergens. This characteristic of E58, and potentially other similar antibodies, suggests an opportunity to develop preventative or therapeutic agents that may inhibit cedar pollen sensitization or prevent their allergic reactions.
Subject(s)
Antibodies, Monoclonal/immunology , Antigens, Plant/immunology , Epitopes, B-Lymphocyte/immunology , Hypersensitivity/immunology , Plant Proteins/immunology , Allergens , Animals , Antibody Specificity , Cedrus/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin E/immunology , Mice , Pollen/immunology , Surface Plasmon ResonanceSubject(s)
Antigens, Plant/immunology , Immunodominant Epitopes/immunology , Immunoglobulin E/immunology , Juniperus/immunology , Plant Proteins/immunology , Rhinitis, Allergic, Seasonal/immunology , Antibodies, Monoclonal/metabolism , Antigens, Plant/chemistry , Humans , Hybridomas , Immunodominant Epitopes/chemistry , Molecular Conformation , Plant Proteins/chemistry , Pollen/immunologyABSTRACT
Cedar pollens cause severe allergic disease throughout the world. We have previously characterized allergenic pollen glycoproteins from mountain cedar (Juniperus ashei) that bind to allergen-specific immunoglobulin E (IgE). In the present report, we investigated an alternative pathway of mast cell activation by mountain cedar pollen extract through IgE-independent mechanisms. We show that mountain cedar pollen directly induces mast cell serotonin and IL-4 release and enhances release induced by IgE cross-linking. Concomitant with mediator release, high levels of intracellular reactive oxygen species (ROS) were generated, and both ROS and serotonin release were inhibited by anti-oxidants. These findings suggest that alternative mechanisms exist whereby pollen exposure enhances allergic inflammatory mediator release through mechanisms that involve ROS. These mechanisms have the potential for enhancing the allergenic potency of pollens.
Subject(s)
Interleukin-4/biosynthesis , Juniperus/immunology , Mast Cells/immunology , Pollen/adverse effects , Animals , Antioxidants/pharmacology , Biogenic Amines/biosynthesis , Cell Degranulation/drug effects , Cell Degranulation/immunology , Cell Line , Humans , Immunoglobulin E/metabolism , Interleukin-4/genetics , Mast Cells/drug effects , Mast Cells/physiology , Pollen/immunology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Reactive Oxygen Species/metabolism , Rhinitis, Allergic, Seasonal/etiology , Rhinitis, Allergic, Seasonal/immunology , Serotonin/biosynthesis , Up-RegulationABSTRACT
It is well known that interfaces, such as polar-nonpolar or liquid-air, play a key role in triggering protein aggregation in vitro, in particular the aggregation of peptides and proteins with the predisposition of misfolding and aggregation. Here we show that the interface present in the lungs predisposes the lungs to form aggregation of inhaled insulin. Insulin inhalers were introduced, and a large number of diabetic patients have used them. Although inhalers were safe and effective, decreases in pulmonary capacity have been reported in response to inhaled insulin. We hypothesize that the lung air-tissue interface provides a template for the aggregation of inhaled insulin. Our studies were designed to investigate the harmful potential that inhaled insulin has in pulmonary tissue in vivo, through an amyloid formation mechanism. Our data demonstrate that inhaled insulin rapidly forms amyloid in the lungs causing a significant reduction in pulmonary air flow. Our studies exemplify the importance that interfaces play in protein aggregation in vivo, illustrating the potential aggregation of inhaled proteins and the formation of amyloid deposits in the lungs. These insulin deposits resemble the amyloid structures implicated in protein misfolding disorders, such as Alzheimer's and Parkinson's diseases, and could as well be deleterious in nature.
Subject(s)
Insulin/administration & dosage , Insulin/metabolism , Insulin/toxicity , Lung Diseases/chemically induced , Proteostasis Deficiencies/chemically induced , Administration, Inhalation , Amyloid/metabolism , Amyloid/toxicity , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Caspase 9/metabolism , Cell Line , Chemical Precipitation , Diabetes Complications/chemically induced , Diabetes Complications/metabolism , Drug Evaluation, Preclinical , Enzyme Activation/drug effects , Humans , Lung Diseases/metabolism , Mice , Mice, Inbred C57BL , Protein Multimerization/drug effects , Protein Multimerization/physiology , Proteostasis Deficiencies/metabolism , Recombinant Proteins/metabolism , Recombinant Proteins/toxicityABSTRACT
BACKGROUND: The prevalence of seasonal allergic diseases of the upper airways is increasing in industrialized countries. The Cupressaceae are important causes of pollinosis, particularly in Europe. OBJECTIVE: To determine whether the pollen from Cupressus sempervirens (Italian cypress) contains a pathogenesis-related group 5 (PR-5) protein, similar to that found in other allergenic Cupressaceae pollens. METHODS: Messenger RNA was purified from Italian cypress pollen, and complementary DNA (cDNA) was synthesized. cDNAs for PR-5 proteins were amplified by polymerase chain reaction and extended by rapid amplification of cDNA ends methods. Recombinant Cup s 3 was expressed in Escherichia coli as a fusion protein. Inhibition enzyme-linked immunosorbent assays were used to test the allergenicity of Cup s 3. RESULTS: Three cDNAs were cloned. These clones had approximately 95% identity to Jun a 3 and Cup a 3. Recombinant Cup s 3.0102 maltose-binding protein inhibited the IgE from most patients from binding to an extract of Italian cypress. The extent of inhibition suggested that antibodies to Cup s 3 were a prominent component of the IgE response to Italian cypress pollen. CONCLUSION: Cup s 3, an allergen of Italian cypress pollen, was identified based on cross-reactivity and homology with other pollen PR-5 proteins, despite an apparently low level of protein expression. Variations in the content of Cup s 3 in the pollen from different regions or trees should be considered in the choice of extracts for diagnosis and specific immunotherapy for Italian cypress pollen hypersensitivity.
Subject(s)
Allergens/genetics , Cupressus/immunology , Pollen/genetics , Rhinitis, Allergic, Seasonal/immunology , Adult , Allergens/immunology , Amino Acid Sequence , Antigens, Plant , Blotting, Western , Cloning, Molecular , Cross Reactions , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Plant Proteins/immunology , Pollen/immunology , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Rhinitis, Allergic, Seasonal/geneticsABSTRACT
The group 1 allergens are a major cause of cedar pollen hypersensitivity in several geographic areas. Allergens from several taxa have been shown to cross-react. The goal of these studies was to compare the structural features of the shared and unique epitopes of the group 1 allergen from mountain cedar (Jun a 1) and Japanese cedar (Cry j 1). An array of overlapping peptides from the sequence of Jun a 1 and a panel of monoclonal anti-Cry j 1 antibodies were used to identify the IgE epitopes recognized by cedar-sensitive patients from Texas and Japan. IgE from Japanese patients reacted with peptides representing one of the two linear epitopes within the highly conserved beta-helical core structure and both epitopes within less ordered loops and turns near the N- and C-termini of Jun a 1. A three-dimensional (3D) model of the Cry j 1, based on the crystal structure of Jun a 1, indicated a similar surface exposure for the four described epitopes of Jun a 1 and the homologous regions of Cry j 1. The monoclonal antibodies identified another shared epitope, which is most likely conformational and a unique Cry j 1 epitope that may be the previously recognized glycopeptide IgE epitope. Defining the structural basis for shared and unique epitopes will help to identify critical features of IgE epitopes that can be used to develop mimotopes or identify allergen homologues for vaccine development.
Subject(s)
Allergens/immunology , Cedrus/immunology , Cross Reactions/immunology , Epitopes/chemistry , Pollen/immunology , Adolescent , Adult , Amino Acid Sequence , Animals , Child , Child, Preschool , Epitope Mapping , Epitopes/immunology , Female , Humans , Immunoglobulin E/immunology , Japan , Male , Middle Aged , Protein Conformation , Rhinitis, Allergic, Seasonal/immunology , TexasABSTRACT
Pollen exposure induces allergic airway inflammation in sensitized subjects. The role of antigenic pollen proteins in the induction of allergic airway inflammation is well characterized, but the contribution of other constituents in pollen grains to this process is unknown. Here we show that pollen grains and their extracts contain intrinsic NADPH oxidases. The pollen NADPH oxidases rapidly increased the levels of ROS in lung epithelium as well as the amount of oxidized glutathione (GSSG) and 4-hydroxynonenal (4-HNE) in airway-lining fluid. These oxidases, as well as products of oxidative stress (such as GSSG and 4-HNE) generated by these enzymes, induced neutrophil recruitment to the airways independent of the adaptive immune response. Removal of pollen NADPH oxidase activity from the challenge material reduced antigen-induced allergic airway inflammation, the number of mucin-containing cells in airway epithelium, and antigen-specific IgE levels in sensitized mice. Furthermore, challenge with Amb a 1, the major antigen in ragweed pollen extract that does not possess NADPH oxidase activity, induced low-grade allergic airway inflammation. Addition of GSSG or 4-HNE to Amb a 1 challenge material boosted allergic airway inflammation. We propose that oxidative stress generated by pollen NADPH oxidases (signal 1) augments allergic airway inflammation induced by pollen antigen (signal 2).
Subject(s)
Allergens/metabolism , Lung/enzymology , NADPH Oxidases/metabolism , Pollen/enzymology , Reactive Oxygen Species/metabolism , Respiratory Hypersensitivity/enzymology , Aldehydes/metabolism , Animals , Bronchoalveolar Lavage Fluid , Epithelium/enzymology , Epithelium/pathology , Glutathione Disulfide/metabolism , Humans , Inflammation/enzymology , Inflammation/pathology , Lung/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Neutrophil Infiltration , Neutrophils/enzymology , Neutrophils/pathology , Oxidation-Reduction , Oxidative Stress , Respiratory Hypersensitivity/pathologyABSTRACT
Pollen from cedar and cypress trees is a major cause of seasonal hypersensitivity in humans in several regions of the Northern Hemisphere. We report the first crystal structure of a cedar allergen, Jun a 1, from the pollen of the mountain cedar Juniperus ashei (Cupressaceae). The core of the structure consists primarily of a parallel beta-helix, which is nearly identical to that found in the pectin/pectate lyases from several plant pathogenic microorganisms. Four IgE epitopes mapped to the surface of the protein are accessible to the solvent. The conserved vWiDH sequence is covered by the first 30 residues of the N terminus. The potential reactive arginine, analogous to the pectin/pectate lyase reaction site, is accessible to the solvent, but the substrate binding groove is blocked by a histidine-aspartate salt bridge, a glutamine, and an alpha-helix, all of which are unique to Jun a 1. These observations suggest that steric hindrance in Jun a 1 precludes enzyme activity. The overall results suggest that it is the structure of Jun a 1 that makes it a potent allergen.
Subject(s)
Allergens/chemistry , Juniperus/chemistry , Plant Proteins/chemistry , Pollen/chemistry , Antigens, Plant , Crystallography , Epitopes/chemistry , Protein Structure, Quaternary , Protein Structure, Secondary , Protein Structure, TertiaryABSTRACT
The high incidence of food allergies, including oral allergy syndrome, represent major considerations when introducing new crops and foods. A new structural database of allergenic proteins, SDAP-Food, http://fermi.utmb.edu/SDAP/, has been developed to aid in predicting the IgE-binding potential of novel food proteins and cross-reactivities among known allergens. The site is designed to facilitate the first steps of a decision tree approach to determine the allergenicity of a given protein, based on the sequence and structural similarity to known allergens and their IgE binding sites. Immunological tests can then be used to confirm the predictions. A hierarchical procedure for identifying potential allergens, using a physical property-based sequence similarity index, has been designed to identify regions that resemble known IgE binding sites. As an example, SDAP tools were used to find food allergen sequences similar to an IgE binding site of the Jun a 3 allergen from mountain cedar pollen. The SDAP sequence similarity search matched the Jun a 3 epitope to regions in several food allergens, including cherry (Pru av 2), apple (Mal d 2) and pepper (Cap a 1), which are, like Jun a 3, members of the plant pathogenesis-related (PR-5) protein family. Homology modeling, using our EXDIS/DIAMOD/FANTOM program suite, indicated a similar surface location and structure for the potential epitope region on all of these allergens. The quantitative approach presented here can be used as part of a screening process for potential allergenicity of recombinant food products.